How did PJP's Momentum indicator behave recently?

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on PJP as a result. In 69 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

What is the significance of the 10-day moving average indicator for PJP?

The 10-day moving average for PJP crossed bullishly above the 50-day moving average on June 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

What does a 3-day price advance indicate for PJP?

Following a +0.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where PJP advanced for three days, in 236 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

PJP

AS OF

Jul 3 closing price

Price

$81.38

Change

+$0.09 (+0.11%)

Net Assets

236.13M

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

PJP

ETF ticker: NYSE ARCA

AS OF

Jul 3 closing price

Price

$81.38

Change

+$0.09 (+0.11%)

Net Assets

236.13M

PJP stock forecast, quote, news & analysis

Q: How does the Aroon Indicator reflect on PJP's trend?

The Aroon Indicator entered an Uptrend today. In 181 of 235 cases where PJP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index... Show more

Category: #Health

Get AI intraday signals

PJP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PJP
(Try 14 days for Free)

A.I.Advisor

published price charts

View to see Real Time Patterns for PJP (Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

a Summary for PJP with price predictions

Jul 03, 2025

PJP in upward trend: 10-day moving average crossed above 50-day moving average on June 06, 2025

The 10-day moving average for PJP crossed bullishly above the 50-day moving average on June 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on PJP as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PJP just turned positive on July 03, 2025. Looking at past instances where PJP's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

PJP moved above its 50-day moving average on June 02, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PJP advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 235 cases where PJP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

PJP broke above its upper Bollinger Band on June 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor

published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Pharmaceuticals ETF ETF is 87.94B. The market cap for tickers in the group ranges from 910.79M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is GERN at 910.79M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Pharmaceuticals ETF ETF was 1%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was -2%. AMGN experienced the highest price growth at 7%, while GERN experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Invesco Pharmaceuticals ETF ETF was -40%. For the same stocks of the ETF, the average monthly volume growth was -54% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56

P/E Growth Rating: 68

Price Growth Rating: 54

SMR Rating: 61

Profit Risk Rating: 66

Seasonality Score: 17 (-100 ... +100)

View a ticker or compare two or three

Compare

PJP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PJP
(Try 14 days for Free)

Interact to see
Advertisement

A.I. Advisor

published General Information

General Information

Category Health

Profile

Fundamentals

Details